You are here

Dupixent

FDA, after delay, clears Regeneron and Sanofi drug for COPD

BioPharma Dive

Mon, 09/30/24 - 09:25 am

Sanofi's Dupixent scores double COPD win in US, China

Pharmaphorum

Mon, 09/30/24 - 09:16 am

3 FDA approval dates to watch in the year’s final push

Pharma Voice

Wed, 09/11/24 - 11:39 am

Bristol Myers Squibb

ATTR cardiomyopathy

Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound

BioPharma Dive

Wed, 09/11/24 - 11:19 am

7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run

Pharma Voice

Tue, 07/30/24 - 11:30 am

Trials to watch: Four biologics concluding pivotal COPD trials

Clinical Trials Arena

Thu, 07/25/24 - 11:36 am

clinical trials

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products

Reuters

Thu, 07/25/24 - 11:26 am

Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD

Fierce Pharma

Wed, 07/3/24 - 11:26 am

Sanofi reports positive data from Phase III EoE treatment trial

Clinical Trials Arena

Thu, 06/27/24 - 11:29 am

eosinophilic esophagitis

clinical trials

Dupixent repeats as top pharma ad brand, rankings largely unchanged in May

Medical Marketing and Media

Tue, 06/11/24 - 10:49 pm

pharma advertising

DTC advertising

Dupixent nears EU approval for COPD, as FDA delays

Pharmaphorum

Fri, 05/31/24 - 10:49 am

Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD

Fierce Pharma

Mon, 05/20/24 - 11:25 am

Dupixent recaptures top Rx, OTC pharma brand spot in April

Medical Marketing and Media

Wed, 05/8/24 - 11:03 pm

DTC advertising

Dupixent’s DU More campaign breathes life into asthma treatment space

Medical Marketing and Media

Mon, 04/29/24 - 09:53 am

DTC advertising

AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again

Fierce Pharma

Fri, 04/26/24 - 11:18 am

atopic dermatitis

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024

BioSpace

Wed, 03/27/24 - 11:06 am

After decades of waiting, late-stage therapies may penetrate the COPD market this year

Clinical Trials Arena

Sun, 03/24/24 - 10:31 pm

drug development

Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial

Fierce Biotech

Mon, 03/11/24 - 11:52 am

clinical trials

prurigo nodularis

Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment

Clinical Trials Arena

Thu, 02/29/24 - 11:11 am

eosinophilic esophagitis

Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD

BioSpace

Fri, 02/23/24 - 10:43 am

priority review

Pages